Study: NCT00297830

Adverse event: Death
Serious: yes
Organ System: General disorders
Frequency: 1 affected / 41 at risk

Adverse event: Hospitalisation
Serious: yes
Organ System: General disorders
Notes: Includes all hospital readmissions after randomization or enrollment.
Frequency: 20 affected / 41 at risk

Adverse event: Infection
Serious: no
Organ System: Infections and infestations
Notes: Includes all infections due to cytomegalovirus and all other infections that necessitated hospitalization, intravenous antibiotic therapy, or both.
Frequency: 14 affected / 41 at risk

Adverse event: Rejection
Serious: no
Organ System: General disorders
Notes: Rejection after month 1 necessitating change in immunosuppressive regimen
Frequency: 4 affected / 41 at risk

Adverse event: Flu-like symptoms after zoledronate or matching placebo
Serious: no
Organ System: General disorders
Frequency: 2 affected / 41 at risk

Adverse event: Hypocalcaemia
Serious: no
Organ System: Endocrine disorders
Notes: Albumin-corrected serum calcium below 8.0 mg/dL.

To convert values for serum calcium to millimoles per liter, multiply by 0.2495.
Frequency: 4 affected / 41 at risk

Adverse event: Serum Calcium > 2.0 mg/dL
Serious: no
Organ System: Endocrine disorders
Notes: At any visit after randomization. To convert values for serum creatinine to millimoles per liter, multiply by 88.4.
Frequency: 1 affected / 41 at risk

Adverse event: Atrial fibrillation
Serious: no
Organ System: Cardiac disorders
Frequency: 2 affected / 41 at risk

Adverse event: Abdominal pain
Serious: no
Organ System: General disorders
Frequency: 1 affected / 41 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 2 affected / 41 at risk

Adverse event: Hospitalisation
Serious: yes
Organ System: General disorders
Notes: Includes all hospital readmissions after randomization or enrollment.
Frequency: 14 affected / 43 at risk

Adverse event: Infection
Serious: no
Organ System: Infections and infestations
Notes: Includes all infections due to cytomegalovirus and all other infections that necessitated hospitalization, intravenous antibiotic therapy, or both.
Frequency: 11 affected / 43 at risk

Adverse event: Rejection
Serious: no
Organ System: General disorders
Notes: Rejection after month 1 necessitating change in immunosuppressive regimen
Frequency: 2 affected / 43 at risk

Adverse event: Flu-like symptoms after zoledronate or matching placebo
Serious: no
Organ System: General disorders
Frequency: 1 affected / 43 at risk

Adverse event: Hypocalcaemia
Serious: no
Organ System: Endocrine disorders
Notes: Albumin-corrected serum calcium below 8.0 mg/dL.

To convert values for serum calcium to millimoles per liter, multiply by 0.2495.
Frequency: 5 affected / 43 at risk

Adverse event: Serum Calcium > 2.0 mg/dL
Serious: no
Organ System: Endocrine disorders
Notes: At any visit after randomization. To convert values for serum creatinine to millimoles per liter, multiply by 88.4.
Frequency: 7 affected / 43 at risk

Adverse event: Abdominal pain
Serious: no
Organ System: General disorders
Frequency: 2 affected / 43 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 43 at risk

Adverse event: Death
Serious: yes
Organ System: General disorders
Frequency: 2 affected / 27 at risk